Conversion therapy with an immune checkpoint inhibitor and an antiangiogenic drug for advanced hepatocellular carcinoma: A review
Tang, HW; Cao, YB; Jian, YP; Li, XR; Li, JF; Zhang, WW; Wan, T; Liu, Z; Tang, W; Lu, SC
Lu, SC (通讯作者),Chinese Peoples Liberat Army Gen Hosp, Fac Hepatopancreatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Lu, SC (通讯作者),Chinese PLA, Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Lu, SC (通讯作者),Chinese PLA, Key Lab Digital IIepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Tang, W (通讯作者),Natl Ctr Global Hlth & Med, Int Hlth Care Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.
BIOSCIENCE TRENDS, 2022; 16 (2): 130